REDWOOD CITY, Calif.--(BUSINESS WIRE)--Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnolo

Here is how Adicet Bio, Inc. (ACET) and Biodesix, Inc. (BDSX) have performed compared to their secto

Gainers Adicet Bio (NASDAQ:ACET) stock moved upwards by 22.9% to $10.14 during Thursday's pre-m

Adicet Bio NASDAQ: ACET outlined its near-term clinical priorities and upcoming data catalysts durin

Here is how Adicet Bio, Inc. (ACET) and Biodesix, Inc. (BDSX) have performed compared to their secto

The average of price targets set by Wall Street analysts indicates a potential upside of 319.6% in A

Adicet Bio (NASDAQ:ACET) reported quarterly losses of $(1.88) per share which beat the analyst conse

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnolo

Adicet Bio (ACET) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the

HC Wainwright & Co. analyst Robert Burns maintains Adicet Bio (NASDAQ:ACET) with a Buy and lo

Guggenheim analyst Yatin Suneja maintains Adicet Bio (NASDAQ:ACET) with a Buy and lowers the pric

Adicet Bio (NASDAQ:ACET) reported quarterly losses of $(2.94) per share which beat the analyst conse

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnolo

Adicet Bio, Inc. (NASDAQ: ACET - Get Free Report) has been assigned a consensus recommendation of "M

Shares of Adicet Bio, Inc. (NASDAQ: ACET - Get Free Report) have received a consensus rating of "Mod

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnolo

HC Wainwright & Co. analyst Robert Burns maintains Adicet Bio (NASDAQ:ACET) with a Buy and ra

Adicet Bio, Inc. (NASDAQ: ACET - Get Free Report)'s share price crossed below its two hundred day mo

Adicet Bio, Inc. (NASDAQ: ACET - Get Free Report) was the recipient of a significant decline in shor

Adicet Bio, Inc. (NASDAQ: ACET - Get Free Report) passed below its 200-day moving average during tra

Adicet Bio, Inc. (NASDAQ:ACET), a clinical stage biotechnology company discovering and developing al

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnolo

Johnson & Johnson reported encouraging Phase 2 results for its experimental lupus drug nipocalim

Adicet Bio, Inc. (NASDAQ: ACET - Get Free Report) was the recipient of a significant growth in short

Shares of Adicet Bio are trading lower after the clinical stage biotechnology company announced a on

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnolo

Shares of Adicet Bio, Inc. (NASDAQ: ACET - Get Free Report) crossed below its 200-day moving average

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnolo

Shares of Adicet Bio, Inc. (NASDAQ: ACET - Get Free Report) have earned a consensus recommendation o

HC Wainwright & Co. analyst Robert Burns maintains Adicet Bio (NASDAQ:ACET) with a Buy and ra

  On Thursday, 369 companies hit new 52-week lows.

  On Wednesday, 311 stocks hit new 52-week lows.

  On Monday, 369 companies set new 52-week lows.

  On Tuesday, 386 stocks made new 52-week lows.

  During the session on Thursday, 461 stocks hit new 52-week lows.

  On Thursday, 148 companies set new 52-week lows.

  Monday saw 196 companies set new 52-week lows.

Gainers Fast Radius, Inc. (NASDAQ: FSRD) shares surged 106.3% to close at $0.21 on Wednesday afte

U.S. stocks closed mostly lower on Wednesday, with the Nasdaq Composite dropping around 175 points.

Gainers Panbela Therapeutics, Inc. (NASDAQ: PBLA) shares jumped 53% to close at $0.58 on Friday.

Stocks Which Set New 52-Week Low Last Trading Session, Fri., Dec. 14, 2018

Stocks Which Set New 52-Week Low Friday, October 26th

Stocks Which Set New 52-Week Low Yesterday, October 23rd